TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Index Pharmaceuticals AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
97,505
|
0
|
110 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
-87,730
|
-94,348
|
-95,570 |
EBITDA |
-88,384
|
-97,334
|
-95,569 |
Total assets |
273,811
|
303,087
|
341,587 |
Current assets |
273,595
|
302,871
|
341,371 |
Current liabilities |
267,939
|
259,574
|
203,798 |
Equity capital |
5,872
|
43,505
|
137,744 |
- share capital |
6,028
![]() |
6,028
![]() |
6,028 |
Employees (average) |
5
|
6
![]() |
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
2.1%
|
14.4%
|
40.3% |
Turnover per employee |
19,501
|
0
|
18 |
Profit as a percentage of turnover | -90.0% | -86881.8% | |
Return on assets (ROA) |
-32.0%
|
-31.1%
|
-28.0% |
Current ratio |
102.1%
|
116.7%
|
167.5% |
Return on equity (ROE) |
-1494.0%
|
-216.9%
|
-69.4% |
Change turnover |
97,505
|
-110
|
110 |
Change turnover % | -100% | ||
Chg. No. of employees |
-1
|
0
|
1 |
Chg. No. of employees % |
-17%
|
0%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.